CD4 decline prior diagnosis of hepatocarcinoma in HIV-infected patients: a new predictor?

• Isabelle Poizot-Martin,
• Olivia Zaegel-Faucher,
• Sylvie Brégigeon,
• Carla E. Cano,
• Corinne Nicolino-Brunet,
• Véronique Obry-Roguet,
• Catherine Tamalet,
• Françoise Dignat-George

Affiliations

Isabelle Poizot-Martin

Aix Marseille University, Sainte Marguerite Hospital, Immuno-Hematological Clinical Unit, Marseille, France; Inserm U912 (SESSTIM), Marseille, France

Olivia Zaegel-Faucher

Aix Marseille University, Sainte Marguerite Hospital, Immuno-Hematological Clinical Unit, Marseille, France

Sylvie Brégigeon

Aix Marseille University, Sainte Marguerite Hospital, Immuno-Hematological Clinical Unit, Marseille, France

Carla E. Cano

Aix Marseille University, Sainte Marguerite Hospital, Immuno-Hematological Clinical Unit, Marseille, France

Corinne Nicolino-Brunet

Aix Marseille University, Conception Hospital, Hematology and Vascular Biology Unit, Marseille, France

Véronique Obry-Roguet

Aix Marseille University, Sainte Marguerite Hospital, Immuno-Hematological Clinical Unit, Marseille, France

Catherine Tamalet

Aix Marseille University, Timone Hospital, Hospital Microbiology Federation, Marseille, France

Françoise Dignat-George

Aix Marseille University, Conception Hospital, Hematology Unit, Inserm, Pharmacology Faculty, Marseille, France